Cinaciguat
Cinaciguat Uses, Dosage, Side Effects, Food Interaction and all others data.
Cinaciguat is under investigation in clinical trial NCT01067859 (A Phase Iib Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 ΜG/h, 10 ΜG/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)).
| Trade Name | Cinaciguat |
| Generic | Cinaciguat |
| Cinaciguat Other Names | Cinaciguat |
| Type | |
| Formula | C36H39NO5 |
| Weight | Average: 565.71 Monoisotopic: 565.28282336 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Cinaciguat
